Fiduciary Trust Co International of Pennsylvania - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 865 filers reported holding BAXTER INTL INC in Q4 2015. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Fiduciary Trust Co International of Pennsylvania ownership history of BAXTER INTL INC
ValueSharesWeighting
Q1 2020$691,000
-1.7%
8,512
+1.3%
0.03%
+23.1%
Q4 2019$703,000
-11.0%
8,402
-7.0%
0.03%
-16.1%
Q3 2019$790,000
+14.3%
9,032
+7.1%
0.03%
+10.7%
Q2 2019$691,000
-15.7%
8,437
-16.4%
0.03%
-20.0%
Q1 2019$820,000
+23.5%
10,0870.0%0.04%
+6.1%
Q4 2018$664,000
-15.4%
10,087
-1.0%
0.03%0.0%
Q3 2018$785,000
+6.9%
10,187
+2.5%
0.03%0.0%
Q2 2018$734,000
+33.0%
9,937
+17.1%
0.03%
+26.9%
Q1 2018$552,000
+9.7%
8,487
+9.1%
0.03%
+18.2%
Q4 2017$503,000
+85.6%
7,780
+79.9%
0.02%
+69.2%
Q3 2017$271,000
-41.1%
4,325
-43.1%
0.01%
-43.5%
Q2 2017$460,000
+34.9%
7,604
+15.6%
0.02%
-11.5%
Q1 2017$341,000
+15.6%
6,580
-1.0%
0.03%
+13.0%
Q4 2016$295,000
-9.8%
6,646
-3.3%
0.02%
-11.5%
Q3 2016$327,000
+1.9%
6,871
-3.2%
0.03%0.0%
Q2 2016$321,000
+7.7%
7,098
-2.0%
0.03%
+4.0%
Q1 2016$298,000
+8.0%
7,2450.0%0.02%
+4.2%
Q4 2015$276,000
+7.4%
7,245
-7.4%
0.02%0.0%
Q3 2015$257,000
-51.0%
7,820
+4.3%
0.02%
-22.6%
Q2 2015$524,000
+1.4%
7,500
-0.7%
0.03%
-6.1%
Q1 2015$517,000
-20.8%
7,550
-15.2%
0.03%
-23.3%
Q4 2014$653,000
+31.4%
8,908
+28.7%
0.04%
+26.5%
Q3 2014$497,000
-0.6%
6,9200.0%0.03%0.0%
Q2 2014$500,000
-1.8%
6,9200.0%0.03%
-8.1%
Q1 2014$509,000
+42.6%
6,920
+34.9%
0.04%
+37.0%
Q4 2013$357,000
+8.2%
5,130
+2.0%
0.03%0.0%
Q3 2013$330,000
-8.8%
5,030
-3.8%
0.03%
-15.6%
Q2 2013$362,0005,2300.03%
Other shareholders
BAXTER INTL INC shareholders Q4 2015
NameSharesValueWeighting ↓
GENERATION INVESTMENT MANAGEMENT LLP 21,171,371$1,817,350,0007.47%
Soditic Asset Management LLP 147,620$12,672,0006.53%
NUANCE INVESTMENTS, LLC 4,084,218$350,589,0006.17%
PRAGMA GESTAO DE PATRIMONIO LTD 145,000$12,4475.96%
Veritas Asset Management LLP 12,222,261$1,049,159,0005.89%
Pavadi Capital LLC 72,782$6,248,0004.74%
Sonen Capital LLC 48,907$4,198,0004.06%
Glenview Capital Management 2,182,422$187,339,0003.99%
Dash Acquisitions Inc. 103,963$8,924,0003.87%
Avidity Partners Management LP 1,765,000$151,508,0003.21%
View complete list of BAXTER INTL INC shareholders